KINVITRAR
LIVE

Serial Number

79185130

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

KINVITRAR Trademark

Serial Number: 79185130 • Registration: 5038603

KINVITRAR is a trademark filed by NOVARTIS AG on February 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 3, 2016

Registration Date

September 13, 2016

Published for Opposition

June 28, 2016

Cancellation Date

March 24, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; biological preparations and stem cells for pharmaceutical and medical purposes

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Jan 21, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 28, 2023 INTS
INVALIDATION PROCESSED
Dec 28, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 24, 2023 INTR
CANCELLED SECTION 71
Mar 24, 2023 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 13, 2021 REM3
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 9, 2017 OPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 24, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 2, 2017 FICS
FINAL DISPOSITION PROCESSED
Feb 2, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 8, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 8, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2016 NONP
REFUSAL PROCESSED BY IB
May 27, 2016 RFNP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 26, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 25, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 25, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 17, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2016 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 9, 2016 RFCS
REFUSAL PROCESSED BY MPU
May 9, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 7, 2016 RFCR
NON-FINAL ACTION WRITTEN
May 6, 2016 CNRT
ASSIGNED TO EXAMINER
May 4, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 1, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 28, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 25, 2016 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 24, 2016 REPR